Cyrille Touzeau, MD, PhD – FDA Inspection, Aug 14, 2026

Record Details

This FDA Inspection record concerns Cyrille Touzeau, MD, PhD, with an inspection on August 14, 2026, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Cyrille Touzeau, MD, PhD
Inspection Date: August 14, 2026
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Dawn C. Olenjack (Issuing Officer)

View Company Profile

ID · bc11cbad-7e3f-4750-830e-f71ec19871ed

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1333064
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cyrille Touzeau, MD, PhD

FDA Inspection

Cyrille Touzeau, MD, PhDAugust 14, 2026